In addition to the Fibroscan, a second non-invasive imaging technique, MRE/MRI Liver MultiScan for detecting steatosis, inflammation and liver fibrosis or stiffness will be conducted. This data will be used to correlate with the presence of NAFLD/NASH. MRI-Liver MultiScan is a post MRI processing software. It involves a specialized magnetic resonance imaging (MRI) technique/sequences that measures fat, iron and fibrosis in the liver using T1 mapping. The procedure has no need for intravenous contrast. LiverMultiScan is currently approved by the FDA for use with Siemens 3T MRI with E11 software. However, this MRI model is not being used at BAMC. Therefore, the use of LMS locally will conducted under an IDE exemption for diagnostic devices (21 CFR 812.2(c))(3). The LMS software will not be used to clinically diagnose subjects. Rather, data will be collected and analyzed by the site and manufacturer (Perspectum) with the knowledge that MRI is not performed in accordance with LMS labeling.